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ABSTRACTS 
 
In this study 100 Sudanese diabetic patients in Khartoum Teaching 
Hospital, japer Abu Aliz Diabetic Center Referred Clinic were 
included (August - December 2000). Diabetic eye disease (cataract 
and Retinopathy) was found to be the commonest complication of 
diabetes and account for 54% of patients followed by neuropathy 
which account for 51 % this is specially found in patients with type 11 
diabetes. It was also shown that the development of the complications 
is directly related to the duration of the disease. 21 % of the patients 
were severely disabled by chronic complications and 38% of the 
working diabetic patients left their work because of diabetes. Poorly 
controlled diabetes and DKA was found to be the most common 
causes of admission to hospital which account for 32% and 28.3% 
respectively, followed by diabetic foot ulcers which account for 
24.5% This found specially in type 11 diabetic patients, where as in 
type I DKA was the most frequent cause of admission to hospital. 
35% of patients were not adherent to their treatment prescriptions 
specially those with type 11 diabetes, 81.5% of them were due to their 
refusal of the medications and the minority (18%) were due to 
unavailability or the high cost of the medications. 
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  ﻣﻠﺨﺺ اﻻﻃﺮوﺣﺔ 
  
ﺴﻜﺮي  ﺑﺎﻟﻌﻴﺎدة ﺑﻤﺴﺘﺸﻔﻰ اﻟﺨﺮﻃﻮم هﺬﻩ اﻟﺪراﺳﺔ اﺟﺮﻳﺖ ﻋﻠﻰ ﻣﺎﺋﺔ ﻣﻦ ﻣﺮﺿﻰ اﻟ
  (.م0002 دﻳﺴﻤﺒﺮ –أﻏﺴﻄﺲ ) اﻟﺘﻌﻠﻴﻤﻲ وﻣﺮآﺰ ﺟﺎﺑﺮ أﺑﻮ اﻟﻌﺰ ﻟﻌﻼج اﻟﺴﻜﺮي 
ﻋﺘﻤﺔ ﻋﺪﺳﺔ ) ﻓﻲ هﺬﻩ اﻟﺪراﺳﺔ وﺟﺪان ﻣﻀﺎﻋﻔﺎت ﻣﺮض اﻟﺴﻜﺮي ﻋﻠﻰ اﻟﻌﻴﻦ 
هﻲ ﻣﻦ أآﺜﺮ ﻣﻀﺎﻋﻔﺎت اﻟﺴﻜﺮي ﺷﻴﻮﻋًﺎ وﺗﻤﺜﻞ ( اﻟﻌﻴﻦ وﺗﺎﺛﻴﺮ اﻟﺴﻜﺮي ﻋﻠﻰ اﻟﺸﺒﻜﻴﺔ 
وهﺬا أآﺜﺮ وﺿﻮﺣًﺎ % 15ﻋﻠﻰ اﻟﺠﻬﺎز اﻟﻌﺼﺒﻲ وﻳﻤﺜﻞ ﻧﺴﺒﺔ وﻳﻠﻴﻬﺎ ﺗﺎﺛﻴﺮﻩ % 45ﻧﺴﺒﺔ 
ﻋﻨﺪ ﻣﺮﺿﻰ اﻟﺴﻜﺮي ﻣﻦ اﻟﻨﻮع اﻟﺜﺎﻧﻲ ووﺟﺪ أن هﻨﺎﻟﻚ ﻋﻼﻗﺔ ﻃﺮدﻳﺔ ﺑﻴﻦ ﻣﺪة اﻟﻤﺮض 
  .وﻇﻬﻮر اﻟﻤﻀﺎﻋﻔﺎت
  
ﻣﻦ اﻟﻤﺮﺿﻲ  ﺳﺒﺐ ﻟﻬﻢ ﻣﺮض اﻟﺴﻜﺮي اﻋﺎﻗﺔ ﺷﺪﻳﺪة ﻧﺘﻴﺠﺔ % 12وﺟﺪان 
ا اﻟﻌﻤﻞ ﺑﺴﺒﺐ ﻣﻦ ﻣﺮﺿﻲ اﻟﺴﻜﺮي اﻟﻌﺎﻟﻤﻴﻦ ﺗﺮآﻮ% 83ﻟﻠﻤﻀﺎﻋﻔﺎت اﻟﻤﺰﻣﻨﺔ ﻟﻠﻤﺮض و 
اﻟﻤﺮض، وﺟﺪان ﻋﺪم اﻧﺘﻈﺎم اﻟﺴﻜﺮ ﻓﻲ اﻟﺪم وﻣﺮض اﻟﺤﻤﺎض اﻟﻜﻴﺘﻮﻧﻲ ﻣﻦ أهﻢ أﺳﺒﺎب دﺧﻮل 
ﻟﻠﺜﺎﻧﻲ وهﺬا أآﺜﺮ ﺷﻴﻮﻋًﺎ % 5.42ﻟﻸول % 23ﻣﺮﺿﻰ اﻟﺴﻜﺮي  ﻟﻠﻤﺴﺘﺸﻔﻰ ﺣﻴﺚ ﻧﺠﺪ ﻧﺴﺒﺔ 
ﻋﻨﺪ ﻣﺮﺿﻰ اﻟﺴﻜﺮي ﻣﻦ اﻟﻨﻮع اﻟﺜﺎﻧﻲ ﻓﻲ ﺣﻴﻦ أن ﻣﺮض اﻟﺤﻤﺎض اﻟﻜﻴﺘﻮﻧﻲ هﻮ ﻣﻦ أآﺜﺮ 
ﻣﻨﻬﻢ % 5.18ﻰ  ﻋﻨﺪ ﻣﺮﺿﻰ اﻟﺴﻜﺮي ﻣﻦ اﻟﻨﻮع اﻟﺜﺎﻧﻲ ، وﺟﺪان أﺳﺒﺎب دﺧﻮل اﻟﻤﺴﺘﺸﻔ
.ﺑﺴﺒﺐ رﻓﻀﻬﻢ ﻟﻠﻌﻼج و اﻻﻗﻠﻴﺔ ﻟﻌﺪم ﺗﻮﻓﺮ اﻟﻌﻼج أو ﺛﻤﻨﻪ ﻋﺎﻟﻲ اﻟﺘﻜﻠﻔﺔ
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ABBREVIATIONS: 
 
DM    Diabetes mellitus 
 
IDDM   Insulin Dependent Diabetes mellitus 
 
NIDDM  Non insulin Dependent Diabetes mellitus 
 
DKA   Diabetic ketoacidosis 
 
IHD   Ischemic heart disease 
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INTRODUCTION & LITERATURE REVIEW 
 
  
 
The term diabetes describes metabolic disorder of multiple etiology 
characterized by chronic hyperglyeaemia with disturbances of carbohydrate, 
fat and protein metabolism resulting from defects in insulin secretion, insulin 
action or both. (1) 
Prevalence varies widely by ethnic group and country (adult rates 
range from < 2% in rural Bantu people in Tanzania to nearly 50% in USA 
pima Indians and South pacific Nauratuns). (2) 
The prevalence of NI DD M is increasing in native Am-rican and 
African-American youth with females more frequently affected than males. 
This increase is related to increasing rates of obesity and to the greater 
demand for insulin at adolescence.(3) 
Rates are also relatively high in "transplanted population" such as 
Asian in Europe and African-Americans, the projected increase in rates, 
hower, is universal.(2)  
Diabetes is a general risk factor for untimely death and makes a 
significant contribution to overall national death rates, particularly for 
circulatory failure.(4) 
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The effect of diabetes includes long term. damage, dysfunction and failure of 
various organs, it may present with characteristic symptoms such as 
polyuria, thirst, bluring of vision and weight loss. In its more severe form 
ketoacidosis or a non-ketotic hyperosmolar state may develop and lead to 
stupor, coma, and in the absence of effective treatment, death. Often 
symptoms are not severe or may be absent and consequently hyperglycemia 
sufficient to cause pathological and functional changes may be present for a 
long time before the diagnosis is made. The long term effect of diabetes 
includes, the progressive development of specific complications.(l) 
 
Complications: 
 
Retinopathy: Which is the common cause of blindness among Individuals 
of working age. The onset of retinopathy is variable. 
(5) Nephropathy: it is found that diabetic nephropathy is the most common 
cause of end stage renal disease (ESRD) and account for abut 35% of ESRD 
population in the United States.(6) 
 Neuropathy: diabetes leads to several recognizable clinic pathologic 
neuropathic syndrome, diagnosis and evaluation requires a thorough history 
and neurologic examination, nerve conduction, electromyography (EMG), 
blood studies and nerve and muscle biopsy in the most severe affected 
patient. Microangiopathy is the common cause of diabetic neuropathy.(7) 
people with diabetes are at increase risk of cardiovascular, peripheral 
vascular and cerebrovascular diseases, with risk of foot ulcers, amputation, 
charcot Joint and features of autonomic dysfunction including sexual 
dysfunction.(l) 
Study was done in the U . K from a routine data describing inpatient care for 
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a 4 year period were analysed (1991/19921994/1995), and confirmed that 
diabetes. is a significant risk factor for prephral vascular disease, infection, 
neuropathy and ulceration.(8) Several pathological processes are involved in 
The development of diabetes, these include processes which destroy the beta 
cells of the pancreas with consequence insulin deficiency and others that 
result in resistance to insulin action. The abnormalities of carbohydrate, fat 
and protein metabolism are due to deficient action of insulin on target tissue 
resulting from insensitivity or lack of insulin.(l) 
Diagnosis of diabetes: 
* In symptomatic patients, a single elevated blood glucose, 11.1mmoI/L 
indicates diabetes. 
. In asymptomatic or mildly symptomatic patients the diagnosis is made on: 
 (a) At least preferably two fasting venous blood glucose above 6.7mmol/L 
(120 mg/dl), the equivalent venous plasma glucose level  is 7.8 mmol/L (140 
mg/dl). 
(b)  At least preferably two random values above 10.0 mmol/L (180mg/dl) in 
venous whole blood or 11.1 mmol/L (200 mg/dl) in venous plasma. 
. A glucose tolerance test (the criteria above should be satisfied) and should 
be reserved for true border line cases.(9)  
The Expert Committee on the Diagnosis and Classification of the American 
Diabetes Association (AD A) has recently recommended the use of fasting 
blood glucose 2> 7 mmol/L as a diagnosis of diabetes mellitus. (10) 
Classification: 
Clinical classification: 
It is recommended that the terms insulin dependent diabetes mellitus 
(IDDM) and non-insulin dependent diabetes mellitus NIDDM no long be 
used. These terms have been confusing and frequently resulted in patient 
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being classified on the basis of treatment rather that pathogenesis. 
1- Type 1: Encompasses the majority of cases which are primarily due to 
pancreatic islet beta-cell destruction and are borne to ketoacidosis. Type 1 
includes those cases attributable to an immune process, as well as those with 
beat-cell destruction and who are borne to ketoacidosis for which neither an 
etiology nor a pathogenesis is known. 
2- Type 11: Includes the common major form of diabetes which results from 
defect in insulin secretion, almost always with a major: contribution from insulin 
resistance,  
3- Malnutrition: 
Malnutrition related diabetes (MRDM), the former subtype of it 
protein'-deficient pancreatic diabetes(PDPD) may be considered as malnutrition 
modulated or modified form of diabetes for which more studies are needed, The 
other subtype of MRDM, fibrocalculous pancreatic diabetes (FCPD) is now 
classified as a disease of the exocrine pancreas, fibrocalculous pancreatopathy, 
which may lead to diabetes mellitus. 
4- Impaired glucose tolerance: 
Is now classified as a stage of impaired glucose regulation, since it can be 
observed in any hyperglycemic disorder, and is itself not diabetes. 
5- Impaired fasting glycaemia: 
It has been introduced to classify individual who have fasting blood glucose 
values above the normal range, but below those diagnostic of diabetes. 
6- Gestational diabetes: 
It is retained now but. encompasses the groups formerly classified as 
gestational impaired glucose tolerance (GIGT) and gestational diabetes 
mellitus (GDM).(1) 
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Etiological classification: 
 (a) Type I: Beta cell destruction, usually leading to absolute insulin 
deficiency. 
(b) Type 11: Predominately insulin resistance with relative insulin 
deficiency or predominantly an insulin secretary defect with or without 
insulin resistance. 
 (c) Other specific types: 
1- Genetic defects of beta-cell destruction. 
2- Genetic defects in insulin action. 
3- Diseases of exocrine pancreas. 
4- Endocrinopathies. 
5- Drugs- or chemical-induce diabetes. 
6- Infections. 
. 7- Uncommon but specific forms of immune-mediated diabetes mellitus. 
a- Anti-insulin receptor antibodies that occasionally found in patient with 
SLE and other auto-immune diseases. 
b- Islet cell autoantibodies is found in patient receiving alpha interferon. 
c- Rare individual develop spontaneous insulin autoantibodies.  
8- Other genetic forms sometimes associated with diabetes such as Down's 
syndrome, Klinefelter's syndrome and Turner.'s syndrome. (I) 
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Treatment: 
Diet: all patients with diabetes require diet therapy, good glycaemic control  
is unlikely to be achieved on insulin or oral therapy when diet is neglected 
especially when the patient is also overweight. 
 Insulin: It is always indicated in patients who have ketoacidosis and is usually 
indicated in patients who present under the age of 40 years  
Sulphonyleureas: It closes A TP- sensitive potassium channel on the B cell 
membrane and the resulting depolarization promote calcium in flux, a signal for 
insulin release, they were in addition believed to increase insulin sensitivity in 
peripheral tissues. (9) In patients with type II diabetes, intensive blood glucose 
control with insulin or sulphonylureas therapy decreases the progression of micro 
vascular disease and' may also reduce the risk of heart attach.(ll) 
Biguanides: The mechanism of action of metformin remain unclear but it reduces 
gluconeogenesis and thus suppresses hepatic glucose output and it increases 
insulin sensitivity ,(9) Since intensive glucose control with metformin appear to 
decrease the risk of diabetes related end point in overweight diabetic patients, and 
is associated with less weight gain and fewer hypoglycemic attacks that are insulin 
and sulphonylureas, it may be the first pharmacological therapy of choice in these 
patients.(ll) 
New diabetic treatment: 
Insulin lispor : the use of it is associated with improved control of . post-prandial 
hyperglycemia (PPHG) and reduce incidence of hypoglycemic episodes. 
Repaglinide: It is a meglitinide analogue, it is a short acting insulin tropic agent 
which when given before meal stimulates endogenous insulin secretion and lowers 
postprandial hyperglycaemia. 
 Amylin analogue: reduces postprandial hyperglycaemia PPHG by slowing 
gastric emptying and delivery of nutrient to the absorbing surface of the gut. 
Glycosidase inhibitors: such as acarbose, migltone and viglibose also reduce post 
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pyramidal hyperglycaemia primary by interfering with carbohydrate digesting 
enzymes and delaying glucose absorption .(12) 
a- glucosidase inhibitors: are a useful and relatively safe therapeutic option in the 
elderly patients with type II diabetes mellitus .(13)  
Thiazolidinedoine TZDs: are a new class of oral antidiabetic agent, they 
selectively enhance or partially mimic certain action of insulin causing a slowly 
generated antihyperglycaemic effect in type II diabetes. This is often 
accompanied by a reduction in concentration of insulin, triglyceride and non 
esterifies fatty acids. (14) 
Health economic: 
Health economic issues that are commonly used include the  following: 
1- Identifying the direct cost related to disease, the care and prevention of a  
disease and its complications.  
2- Identifying the indirect cost associated with the disease. This include the cost of 
lost productivity through sick leave, disability or premature mortality . 
3- Identifying the cost to the individual, which includes out-of-pocket payments 
associated with health care, caregivers expenses and the sacrifices in time made in 
searching for medical care, employment and insurance. 
4- Identifying the most efficient use of health care resources. The most common 
report in literature are descriptive studies of the cost- effectiveness of diabetes 
interventions. These have been best developed in North America, particularly in 
USA, other health care settings particularly those of developing countries have 
been much less intensively studied .(15) 
Describing the Cost of disease: 
Studies that describe the economic costs of diabetes have been used as an 
argument for the al1ocatioll of either more or the same level of resources in the 
future.   
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Direct costs: 
Direct costs are the costs of items such as medication, equipment, 
hospital and nursing- home care, and also expense incurred by individuals 
and their families as a result of the disease.  
Indirect Costs: 
Include the consequences of morbidity, disability and primitive 
mortality resulting from diabetes.  
Other costs: 
Other disease related costs also exist which affect the individual and 
society. These include psychosocial or intangible costs, such as stress, pain 
and anxiety which are concerned with the loss of quality of life which might 
be associated with the diagnosis of a chronic disease are,  therefore, more 
subjective.(5) 
The impacted diabetes on the individual: 
Mortality and morbidity of people with" diabetes: 
The major part of the burden of people with diabetes is their reduced 
quantity and quality of life. Life expectancy for people with diabetes is, even 
in developed countries, considerably lower than for people without the 
disease. 
In the US, type I diabetes mellitus reduces life expectancy by 15 years 
or more for people diagnosed before the age of 30 years 
 This difference is criminated by increasing age, since people with  
type I diabetes at age of 70 years or above experienced little  reduction in 
life expectancy. However, there is evidence from other countries with 
different models of care that the gap of life expectancy is less.(l8) 
In many developing countries mortality from the immediate effects of 
diabetes, particularly. ketoacidosis is very high, not only do people with 
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diabetes have reduced life expectancy, they also experience increased 
morbidity inducing anxiety and depression. (19)  
This increase morbidity lead to a higher rates and longer duration of 
hospitalization due to acute and chronic complications. The most effective 
way of preventing the immediate and long-term microvaswler complications 
of diabetes is by achieving good metabolic control through intensive self 
care. It is also the most effective way of decreasing the use and, therefore, 
the cost of inpatient care for people with diabetes.(20) 
Tile financial burden of people with diabetes: 
The diagnosis of chronic disease such as diabetes necessitates major 
changes in life style. These often result in stress, pain and anxiety. Even in 
countries where health care is free these life style changes have economic 
consequences, either as tangible direct or indirect costs or intangible 
(psychosocial cost). These are not usually considered in cost of-illness 
studies because of the problem of quantifying them. Such costs are however, 
important to people of diabetes and their families and careers and must be 
mentioned when cost-of-iJ1ness studies are carried out. Some cost incurred 
by the individuals can be more clearly described e.g.  
i   Out-of-pocket expenses for health- care. 
ii  Cost of life style changes. 
Iii  Loss of income.(15) 
Out-of-pocket expenses for health care: 
The average out of pocket expense for health care for a person with diabetes 
in the USA in 1977 amounted to roughly US$ 335, compared with US $ 184 
for a person without diabetes.(20)  
In many developing countries the public coverage of health care costs 
is very low. This leads to barriers in access to care for people with diabetes. 
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It is likely to increase their morbidity and premature mortality and to lead to 
financial ruin for many families.(15)  
Cost of life style changes:  
 Ninety percent of people with diabetes have type II diabetes, for them 
modification of diet and increase physical activity are central to treatment, 
changing the habit of life style is difficult, and people may not be willing to do so . 
The same life style modifications are important in type I diabetes, but for both 
group the recommended diet can be expensive, requiring a high intake of fruit and 
vegetables. 
Similarly access to exercise facilities and physical activity programme may 
be expensive. 
Recommending health-operating life-style implies that people with 
diabetes have the economic freedom to choose between healthy and unhealthy 
ways of living. However, in many instances people have little control over these 
aspects of life: their food and patterns of work and leisure are determined by harsh 
necessity.  
Loss of income: 
Many countries impose restriction on the type of employment which may 
be undertaken by people with diabetes e.g. they may not be allowed to work in the 
arm forces, the fire service, or be pilots or drive trains. However, employment 
restriction differ remarkably between countries .(15) 
In some places, diabetes may restrict people from working at all, whereas in 
other it has no effect on employment. Relatively few studies of employment 
characteristics of people with diabetes has been out, those that are available 
have recently been reviewed. The existing evidence seem to suggest that 
younger people particularly men with diabetes do experience more difficulty in 
finding employment when compared with people without diabetes.(21) 
Older employee may loose their job on first diagnosis or when such 
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complication such as retinopathy arise. Absenteeism from work due to 
sickness is not significantly greater, overall, in people with diabetes than is 
those without, although when there is difference, it is usually restricted to 
those treated with insulin and those suffering from complications. 
Permanent disabilities induced by chronic complication led to diabetes 
being the third most important cause of permanent retirement of employees of 
the government of the province of Buenos Aires, Argentina in the period of 1984 -
1986.(22) 
Reducing the burden of diabetes: 
Demography and epidemiological evidence suggest that without 
effective intervention the prevalence of diabetes and its sequel will continue 
to increase. This has led the WHO to conclude that "an apparent epidemic of 
diabetes has occulted which is strongly related to lifestyle and economic 
change". The increase in prevalence of diabetes and its complications, as 
well as decreasing the quality of life of individual and their families will 
have severe economic consequences for them and for their families 
Primary prevention: 
Referred to activities aimed at preventing diabetes from developing in 
susceptible individuals, either through the modification of environmental and 
behavioral risk factors or through specific therapeutic intervention. Within the last 
decade several advances had been made in methods of identifying people at 
increase risk of developing diabetes. Moreover, there is evidence, albeit limited 
that some intervention may help to reduce this risk inusceptible people. (15) 
Secondary and tertiary prevention: 
 Secondary prevention is the early detection of the disease process (e.g. 
through screening) and intervention to stop or slow down its progression. Tertiary 
prevention is intervention designed to reduce the consequences of the disease and 
aid rehabilitation. The adequate treatment of diabetes, the early detection of it,s 
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complication and their control are important objectives. Indeed the prevention of 
acute and chronic complications such as diabetic ketoacidosis, retinopathy, 
nephropathy and neuropathy are major goals of diabetes management, since they 
help to prevent deterioration in the person's quality of life and are beneficial 
economically .(15) 
Prevention and aggressive treatment of glucose intolerance and the other 
adverse metabolic conditions associated with type II diabetes will not only have a 
positive effect on the quality of life, but also provide long-term cost-saving .(23) 
The cost effectiveness of secondary and tertiary prevention: 
    As diabetes complications account for over 60% of diabetic health care 
expenditure in many countries, reducing the prevalence and severity of diabetic 
complications may have long term implications, not only for people with diabetes 
but for society as a whole. Obviously, providing health care to prevent and treat 
diabetic complications requires resources. However, the cost of not doing so may 
be much greater.(15) 
Early detection and treatment of diabetic complications: 
     Meriting good glycaemic control helps to prevent diabetic complications and 
they reduce the associated cost. Another important way to reduce these costs is by 
detecting and treating complications early. 
Diabetic retinopathy: 
       Prevention strategies such as the early detection of retinopathy and laser 
photo-coagulation therapy have been shown to be effective in preventing 
blindness. When investigating the effects of vision loss on quality of life, Jault and 
Aiello showed that screening programme for diabetic retinopathy are cost. 
Effective when compared with other established procedures for people with type I 
and people with type II diabetes. 
In general primary health-care-based solutions when they are effective, 
compared favorably with other options, but more sophisticated ways of screening 
still showed reasonable cost-effectiveness .(I5) 
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Renal failure: 
An evaluation by Siegel et al. (24) showed that screening for micro 
albuminoidal by saves life but at quite a substantial cost per life-year saved. A 
further study by Borch J, et al. (25) indicates that micro albuminoidal screening is 
cost saving when reasonable assumptions about the effect of ACE inhibitors are 
made. (routine ACE inhibitors therapy could prove to be cost-effective especially 
if high risk individuals could be identified ) (26) 
Foot problem: 
Evidence exists to suggest that good foot care and effective antibiotics and 
surgical management of foot ulcers can prevent lower extremity amputation if 
instituted early. Properly fitting shoes and avoidance of foot trauma are 
cornerstone preventive treatment. (27) 
Education about foot care and access to appreciate footwear are vitally 
important. Given the-high cost of ulcers and amputation to both individual and 
society, the relative low-cost interventions of foot care are likely to be cost-
effectiveness in most societies .(I5)  
Tight glycaemic control and symptomatic therapy are beneficial  in some 
patients, but does not prevent progression of neuropathy especially in patients with 
motor and gate disability.(28) 
Organization of health care: 
A- Primary health care: 
It is the most common entry point to diabetes management in most 
countries, with between 700/0 of type II diabetes being managed by their 
primary care physician.(29) Diabetes care at this level offers several 
advantages which include ease to access and holistic approach, with diabetes 
care forming just one part of the total medical package.(30)  The customization 
and systemic implementation of practice guidelines by local primary care 
providers was associated with improved diabetic foot care outcome  
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B- Secondary and tertiary health care: 
It is needed for people with significant complications or other 
comorbid conditions, pregnant women, children and adolescents. There is 
also evidence to suggest that primary health professionals are reluctant to 
treat insulin requiring or insulin dependent individuals.(15)  
Education and training: 
Active participation from the person with diabetes is required for 
successful diabetes management, therefore, education is the cornerstone for 
diabetes care. While the cost of providing education may appear high, the cost of 
not providing it may be much higher. 
 Corny and Helliw (13) showed that ongoing training programme help to 
improve the standard of clinical care provided for people with diabetes, which 
would imply improved diabetes outcome and hence reduced cost. 
Education must also be provided for health care professionals Education at 
both level should be seen as an integral component of any country's initiative to 
reduce the burden of diabetes. There is no doubt that diabetes is a costly disease in 
term of its personal and financial impact. However, this burden can be reduced, 
while there is no suggestion that we can prevent diabetes altogether, great progress 
has been made in prevention and treating diabetic complications. This involves 
improving glycaemic control and treating risk factors for the development of 
diabetic complications, as well as other effective preventive care strategies, such 
as screening for retinopathy and laser photocoagulation to prevent blindness, early 
detection of foot ulceration and treatment to prevent amputation, and patient 
education to reduce hospital bed occupancy and improve the quality life of people 
with diabetes.  
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OBJECTIVES 
1- To determine the most frequent cause of admission to hospital in diabetic 
patients. 
2- To estimate the physical disability among diabetic patients and their 
performance at work. 
3- To determine the direct and indirect costs attributable to diabetes. 
4- To evaluate the patient adherence to the treatment prescription. 
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PATIENTS & METHODS 
Type of the study: 
 
This is a retrospective descriptive study where 100 diabetic patients 
were included. 
 Study area and period: 
 Khartoum Teaching Hospital and Japir Abu Aliz Diabetic Center 
Referred Clinics in 3 month period from August to December 2000 . 
Study Techniques: 
 All patients were studied by unifying protocol consisting of 
standard questionnaire and clinical examination, sex, age, type of diabetes, 
type of treatment, duration of the disease, degree of disability, common 
causes of admission to hospital, performance at work and compliance to 
treatment were noted from the history.  
Complications were determined from the examination. Diabetic eye 
disease was determined by eye examination and fundoscopy, neuropathy by 
full neurological examination of the patients, Ischemic heart disease from 
previous ECGs of the patients, nephropathy by urine general examination, 
whereas diabetic foot ulcers and amputation were determined by general 
examination of the patients. 
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RESUL TS 
I n this study 100 Sudanese diabetic patients in Khartoum Teaching 
Hospital and Japir Abu Aliz Diabetic Center Referred Clinics in a three 
month period from August to December 2000 were included.  
Table1 shows sex distribution, 52 males and 48 females.  
Table 2 shows age distribution, 20% of patients were < 30 years and 
80% were> 30 years of age.Fifty one percent of patients their duration 
of the disease < 10 years and 49%, > 10 years (Table 3).  
Table 4 demonstrates the type of diabetes, where 18% of patients were 
type I and 82% were type 11. 
Fig. 1 shows the complications of diabetes in the study group. 
51 % have neuropathy, diabetic eye diseases (retinopathy and 
cataract) 
54%, nephropathy 8%, ischemic heart disease 18%, diabetic foot ulcer 
29%, amputation 6%. 
Fig. 2 shows complications of diabetes in type I and in type II 
diabetes, in type I neuropathy, 33.3%, diabetic eye disease 33.3%, 
diabetic foot ulcer 38%, amputation 11 % and there is 0% in 
nephropathy and ischemic heart disease. 
In type 11 neuropathy were 52.4%, diabetic eye disease 58%, diabetic 
foot ulcer 26%, amputation 5%, nephropathy 10% and ischaemic heart 
disease were 22%. 
Fig. 3 demonstrates complications- of diabetes according to the 
disease duration. In patients with less than 10 years duration, 
neuropathy 65%, diabetic eye disease 46%, nephropathy 7.5%, IHD 
16%, diabetic foot ulcer 14% and amputation 5.5%. The patient with 
more than 10 years duration, neuropathy 57%, diabetic eye disease 
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73%, nephropathy 8%, IHD 2.5%, diabetic foot ulcer 45% and 
amputation 6%. The degree of disabiJity was demonstrated in Fig. 4, 
it was found that 21 % of patients were severely disabled by chronic 
complications of diabetes, 7% of patients were moderately disabled 
and 62% were mildly disabled. 
Fig. 5 shows the degree of disability according to the type of diabetes. 
In type I 38% were severely disabled by the chronic complications, 
6% moderately disabled and 56% mildly disabled. In type II 17% 
severely disabled, 19%, moderately disabled and 64% mildly disabled. 
Common causes of admission to hospital was shown in Fig. 6,  
28.3% was due to DKA, hypoglycemia 7.6%, diabetes foot ulcer 
24.5%, bad control 32% and ischemic heart disease 3%. 
Fig. (7) demonstrates common causes of admission to hospital in type 
I and in type II diabetic patients. In type I DKA 53%, hypoglycemia 
7% , diabetic foot ulcer 4% bad control 26% and 0% for IHD. In type 
II DKA  3%, hypoglycemia 8%, diabetes foot ulcer 32%, bad control 
36% and 11% for IHD. 
46% of working diabetic left their work because of diabetes,16% their 
performance at work wae deteriorated and 37% their performance was 
not affected (Fig. 8).  
It is found that 71. % of patients were adherent to the treatment 
prescription and 29% were not adherent (Fig. 9).  
Fig. (10) shows the compliance to treatment in type I and in type II 
diabetic patients. In type I 55%had good compliance and 45% had bad 
compliance. In type II 74% had good compliance and 26% had poor 
compliance. 
Causes of non-compliance to the treatment (Fig. 11), It was found that 
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81.5% refuse their medications, 7.4 were not adherent because of 
unavailability of the medications, 7.4% due to the high cost of the 
medication and 3.1 % because the medications were far from their 
home. 
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Sex distribution in 100 diabetic patients 
 
Sex No. of patients % 
Males 52 52 
Females 48 48 
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Age distribution in 100 diabetic patients 
 
Age (in years) No. of patients % 
< 30 20 20 
>30 80 80 
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The duration of disease in 100 diabetic patients 
 
Duration (in yea.os) No. of patients (Yes) 
< 10 51 51 
> 10 49 49 
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Type of diabetes in 100 diabetic patients 
 
Type of diabetes No. of patients (Yes) 
Type I diabetes 18 18 
Type Il diabetes 82 82 
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PATIENTS & METHODS 
Type of the study: 
 
This is a retrospective descriptive study where 100 diabetic patients 
were included. 
 Study area and period: 
 Khartoum Teaching Hospital and Japir Abu Aliz Diabetic Center 
Referred Clinics in 3 month period from August to December 2000 . 
Study Techniques: 
 All patients were studied by unifying protocol consisting of 
standard questionnaire and clinical examination, sex, age, type of diabetes, 
type of treatment, duration of the disease, degree of disability, common 
causes of admission to hospital, performance at work and compliance to 
treatment were noted from the history.  
Complications were determined from the examination. Diabetic eye 
disease was determined by eye examination and fundoscopy, neuropathy by 
full neurological examination of the patients, Ischemic heart disease from 
previous ECGs of the patients, nephropathy by urine general examination, 
whereas diabetic foot ulcers and amputation were determined by general 
examination of the patients. 
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RESUL TS 
In this study 100 Sudanese diabetic patients in Khartoum Teaching 
Hospital and Japir Abu Aliz Diabetic Center Referred Clinics in a three 
month period from August to December 2000 were included.  
Table1 shows sex distribution, 52 males and 48 females.  
Table 2 shows age distribution, 20% of patients were < 30 years and 
80% were> 30 years of age.Fifty one percent of patients their duration 
of the disease < 10 years and 49%, > 10 years (Table 3).  
Table 4 demonstrates the type of diabetes, where 18% of patients were 
type I and 82% were type 11. 
Fig. 1 shows the complications of diabetes in the study group. 
51% have neuropathy, diabetic eye diseases (retinopathy and cataract) 
54%, nephropathy 8%, ischemic heart disease 18%, diabetic foot ulcer 
29%, amputation 6%. 
Fig. 2 shows complications of diabetes in type I and in type II 
diabetes, in type I neuropathy, 33.3%, diabetic eye disease 33.3%, 
diabetic foot ulcer 38%, amputation 11 % and there is 0% in 
nephropathy and ischemic heart disease. 
In type 11 neuropathy were 52.4%, diabetic eye disease 58%, diabetic 
foot ulcer 26%, amputation 5%, nephropathy 10% and ischaemic heart 
disease were 22%. 
Fig. 3 demonstrates complications- of diabetes according to the 
disease duration. In patients with less than 10 years duration, 
neuropathy 65%, diabetic eye disease 46%, nephropathy 7.5%, IHD 
16%, diabetic foot ulcer 14% and amputation 5.5%. The patient with 
more than 10 years duration, neuropathy 57%, diabetic eye disease 
73%, nephropathy 8%, IHD 2.5%, diabetic foot ulcer 45% and 
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amputation 6%. The degree of disabiJity was demonstrated in Fig. 4, 
it was found that 21 % of patients were severely disabled by chronic 
complications of diabetes, 17% of patients were moderately disabled 
and 62% were mildly disabled. 
Fig. 5 shows the degree of disability according to the type of diabetes. 
In type I 38% were severely disabled by the chronic complications, 
6% moderately disabled and 56% mildly disabled. In type II 17% 
severely disabled, 19%, moderately disabled and 64% mildly disabled. 
Common causes of admission to hospital was shown in Fig. 6,  
28.3% was due to DKA, hypoglycemia 7.6%, diabetic foot ulcer 
24.5%, bad control 32% and ischemic heart disease 3%. 
Fig. (7) demonstrates common causes of admission to hospital in type 
I and in type II diabetic patients. In type I DKA 53%, hypoglycemia 7 
, diabetic foot ulcer  4%, bad control 36% and 0% for IHD. In type II 
DKA 3%, hypoglycemia 8%, diabetes foot ulcer 32%, bad control 
46% and 11% for IHD. 
46% of working diabetic left their work because of diabetes,16% their 
performance at work deteriorated and 38% their performance was not 
affected (Fig. 8).  
It is found that 71. % of patients were adherent to the treatment 
prescription and 29% were not adherent (Fig. 9).  
Fig. (10) shows the compliance to treatment in type I and in type II 
diabetic patients. In type I 55%had good compliance and 45% had bad 
compliance. In type II 74% had good compliance and 26% had poor 
compliance. 
Causes of non-compliance to the treatment (Fig. 11), It was found that 
82% refuse their medications, 7.4%  were not adherent because of 
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unavailability of the medications, 7.40/0 due to the high cost of the 
medication and 3.2 % because the medications were far from their 
homes. 
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Sex distribution in 100 diabetic patients 
 
Sex No. of patients % 
Males 52 52 
Females 48 48 
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Age distribution in 100 diabetic patients 
 
Age (in years) No. of patients % 
< 30 20 20 
>30 80 80 
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The duration of disease in 100 diabetic patients 
 
Duration (in yea.os) No. of patients (Yes) 
< 10 51 51 
> 10 49 49 
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Type of diabetes in 100 diabetic patients 
 
Type of diabetes No. of patients (Yes) 
Type I diabetes 18 18 
Type Il diabetes 82 82 
 
 43
  DISCUSSION 
There is male predominance in this study with 80% of the 
patients were over  and this is because most of the patients included had 
type II diabetes which is comparable with a worldwide distribution of 
diabetes. (9)Half of the patients their disease duration> 10 years. a 
similar study was done in Sudan March 2000 (32)to demonstrate 
hospitalization pattern in diabetic patients in Sudan. It also showed 
male predominance with most of the patients, their age> 30 years and 
have type II diabetes, and half of them their disease duration> 10 years. 
Diabetic eye disease (cataract and retinopathy) was (found to be the 
commonest complication of diabetes in this study, so diabetes is a 
costly disease, it cost about 5 million Sudanese Dinar per year for the 
treatment of diabetic eye disease in patients who were treated in Eye 
Teaching Hospital. A similar study was done in USA in 1987 which 
showed that IHD was the commonest complication of diabetes, the 
difference here because IHD is more prevalent in Western casuistries 
.(33) When we compare the complications in type I and type II 
diabetes, we found that, neuropathy and diabetic eye disease were the 
commonest complications in type I . A similar study was done in Japan 
1999, which showed the same results. In type II diabetic patients, also 
we found diabetic eye disease was the frequent complication. A similar 
study was done in Philippines (2000).(35)However, another study was 
done in USA(36)which showed that cardiovascular disease is the most 
frequent and costly complications of type II diabetes, this is because 
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cardiovascular and ischemic heart disease are more prevalent in 
Western countries. 
In this study it was found that the frequency of diabetic 
complications in general increased by the duration of the disease, this is 
comparable with study done in France 2000.(37) However, the 
differences in complications rate between type I and type II diabetes 
were largely due to the differences in duration of diabetes and 
glycaemic control rather than the type of diabetes. 
More than one-fifth of the patients were severely disabled by 
chronic complications. This is comparable with. the study done in 
USA. (38)The disability is more marked in type I diabetic patients in this 
study, this is because type I starts at a young age group. Badly 
controlled of diabetes and DKA were found to be the commonest 
causes of admission to the hospital, (this is cost about 15 million 
Sudanese Dinars per year for patients who were treated in Khartoum 
Teaching Hospital). This is comparable with study done in Sudan in 
2000(32)and other study done in the King Abdelaziz University Hospital 
in 1999.(39)  In this study in type I diabetic patients DKA is the 
commonest cause of admission, this similar to study done in USA 
2000.(40)In type II badly control diabetes was found to be the 
commonest cause of admission in this study. Another study was done 
in UK (2000) showed that myocardial infarction is the commonest 
cause of admission in type II diabetes.(41)This because ischemic heart 
disease is more prevalent in these countries. 
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More than one-third working diabetic patients left their work 
because of diabetes, (so diabetes causes loss of income which costs 
0.24 million Sudanese Dinars for every patients per year. In addition to 
the other disease related cost which affect the individual and society, 
this include psychosocial or intangible costs such as stress, pain and 
anxiety which are concerned with the loss of quality of life) and one-
fifth of them their performance at work deteriorated, this is comparable 
with study done in Argentine in 1991.(22) 
More than one-third of patients were not adherent to treatment 
prescriptions, which is more obvious in type I diabetic patients, this is 
because of the problems of insulin availability, high cost and storage, 
this is comparable with study done in Sudan in 2000.(32)Another study 
was done in India (1999).(42) Those who were not adherent to their 
treatment, minority of them were due to unavailability and high cost of 
the medications, but the majority of them refuse their medications. This 
is comparable with study done in Sudan in 2000.(32)  
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CONCLUSION 
1- Diabetes is a significant health problem resulting in substantial 
Morbidity and mortality. 
2- Poorly controlled diabetes was found to be the commonest cause of 
admission to hospital in this study. 
3- Diabetic eye disease was found to be the frequent complication of 
diabetes. 
4- Permanent disability induced by chronic complications was found to 
be a major economic burden in this study. 
5- Diabetes is a major cause of absenteeism and retired ness from work. 
6- It was noted that more than third of diabetic patients were not 
adherent to the treatment prescriptions. 
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RECOMMENDATIONS 
1- The human and economic costs of diabetes could be effectively 
reduced by investing in prevention, particularly the early detection  and 
prevention of diabetic complications. 
2- Public and professional awareness of the risk factors for and 
symptoms of, diabetes are important step towards its control and 
prevention. 
3- Action taken early in the course of diabetes is more beneficial in 
terms of quality of life and more cost-effective. 
4- Without appropriate training of primary health care professionals, 
the cost effectiveness of diabetes prevention is not suitable, training is 
therefore, crucial to the cost effectiveness of preventive diabetic care. 
5- Education of people with diabetes and their career is an important 
factor in ensuring that treatment is effective and is maintained. 
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 ﻢﻴﺣﺮﻟا ﻦﻤﺣﺮﻟا ﷲا ﻢﺴﺑ 
Questionnaire 
 
Cost of Diabetes 
Serial No: ………………     Date: …………… 
1.  Name: …………………………………………………………………….. 
2. Age  : ……………………………………………………………………… 
3. Sex   : ……………………………………………………………………… 
4. Duration of the disease :…………………………………………………… 
………………………………………………………………………………... 
5. Type of drug treatment: …………………………………………………… 
6. Did you admitted to hospital before?    a/ Yes                  b/ No 
7. the couse 6 admission : 
a. DKA 
b. Hypoglycemia  
d. Diabetic foot ulcer   
d. Bad control  
e. IHD 
8. Complications on examination  
 a. Neuropathy 
b. Diabetic eye disease    
c. Nephropathy 
d. IHD 
E. Diabetic foot ulcer   
f. Amputation  
9. Do you take your medication regularly : 
   a. Yes    b. No  
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10. If No, Why? 
a. Unavailability of medication 
b. Refusal of Medication  
d. High cost of medication  
e. Far from home  
 11. on examination, the degree of disability  
 a. Severe  
b. Moderate  
c. Mild  
12. What is your performance at work? 
a. Deteriorated 
b. Not affected  
c. Left their work  
 
 
 
 
 
 
 
